The largest database of trusted experimental protocols

10 protocols using mda mb 231 luc

1

Establishment of Luciferase-Expressing Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Luciferase-expressing cancer cell lines (human breast cancer cells MDA-MB-231-Luc, murine melanoma cancer cells B16-F10- Luc, and murine mammary cancer cells 4T1-Luc) were obtained from Caliper Life Sciences (Hopkinton, MA). Detailed construction of the lentiviral vector system, transfection, and characterization of stable cell lines were previously reported [22 (link), 23 ]. All three cell lines were cultured in RPMI 1640 medium (HyClone, UT) supplemented with 10% heat inactivated fetal bovine serum (HyClone, UT) without antibiotics and tested negative for human and rodent pathogens prior to initiation of the animal studies. A single cancer cell suspension was prepared for tumor induction in Hanks Balanced Salt Solution with greater than 95% viability as evaluated by trypan blue staining.
+ Open protocol
+ Expand
2

Culturing Human Breast Cancer and Non-Malignant Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human breast cancer and non-malignant epithelial cells were obtained from the American Type Culture Collection (Rockville, MD, USA). MDA-MB-231 cells stably expressing luciferase (MDA-MB-231-Luc) were obtained from Caliper Lifesciences (Hopkinton, MA, USA). All cell culture media contained 10% FBS and 1% penicillin–streptomycin unless otherwise specified. Human MCF-7, MDA-MB-231 and MDA-MB-435 cells were grown in DMEM media. The MCF-7 p53 KD and MCF-7 MDM2 KD inducible cells were generated using the previously described method53 (link),54 (link) and were grown in the same media as MCF-7 cells, but supplemented with 0.5 μg ml −1 puromycin or 10 μg ml −1 blasticidin and 0.5 μg ml −1 puromycin (Sigma-Aldrich Co.), respectively. MDAMB-468 cells were grown in DMEM/F-12 Ham’s media (DMEM/F-12 1:1 mixture). The MCF-10A growth medium was composed of DMEM/F-12, supplemented with 5% donor horse serum, 20 ng ml −1 epidermal growth factor, 10 μg ml −1 insulin, 0.5 μg ml −1 hydrocortisone (Sigma-Aldrich Co.) and 100 μg ml −1 cholera toxin (Cambrex, Westborough, MA, USA). Human MDAMB-231-Luc cells were grown in DMEM media containing 0.1 mM MEM non-essential amino acids and 2 mM L-glutamine.
+ Open protocol
+ Expand
3

Culturing Triple Negative Breast Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human triple negative breast cancer cell line MDA-MB-231 was obtained from cell bank of the China Science Academy (Shanghai, China). Human umbilical vein endothelial cells (HUVECs) were purchased from ATCC (Rockvile, United States). The MDA-MB-231cell line labeled with luciferase (MDA-MB-231-luc) was supplied by Caliper (Hopkinton, United States). Cells were cultured in RPMI-1640 medium (Gibco, CA, United States) supplemented with 10% fetal bovine serum (Gibco, CA, United States) at 5% CO2, 37°C.
+ Open protocol
+ Expand
4

Primary Tumor Cell Isolation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
A549-luc, BXPC-3-luc, HT-29-luc, Hela-luc, MDA-MB231-luc, NCIH460-luc, PC-3M-luc, and LL/2-luc-M38 cell lines were all purchased from Caliper Life Sciences. U87MG-luc cells were generated by our group previously [35 ]. The primary culture was derived from freshly isolated tumor cell from patients of two primary lung cancer or two primary breast cancer individually, in Beijing Shijitan Hospital of Capital Medical University. The consent was obtained from the patients before sample collection. The study complied with the Declaration of Helsinki and was approved by the Biomedical Research Ethics Committee of Beijing Shijitan Hospital of Capital Medical University. Briefly, tumors were placed into RPMI1640 medium with antibiotics and anti-fungal immediately following resection. Specimens were washed with cold PBS repeatedly to remove blood clots and tissue debris, and then minced into 0.5- to 1.0-mm pieces. The tissue pieces were digested with collagenase IV, Dnase I and hyaluronidase. Then cells were washed and passed through a 70 μm cell strainer to obtain single-cell population. All agents for cell culture were from Gibco Company (Gaithersburg, MD, USA). Beige-SCID Mice (8 to 10 weeks) were purchased from Vital River Laboratories (VRL, Beijing, China).
+ Open protocol
+ Expand
5

Culturing Human Cancer and Normal Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human cancer cell lines, A2058, AsPC-1, SKNSH, MiaPaCa-2, cfPac-1, NCI-H460, H1915, H1299, U87MG and U373 and the normal pancreatic cell line (HPDE) were obtained from ATCC (Manassas, VA, USA). MDA-MB-231-luc- were obtained from Caliper Life Sciences (Mountain View, CA, USA). HUVEC were from Lonza (Basel, Switzerland). HPDE, A2058, AsPC-1, MiaPaCa-2, cfPac-1, U87MG, Gli36 and U373 were cultured in DMEM (Fisher Scientific, Pittsburgh, PA, USA). H460, H1299 and H1915 were cultured in RPMI 1640 (Fisher Scientific). MDA-MB-231- Luc and SKNSH were cultured in AMEM (Invitrogen, Carlsbad, CA, USA). The above cell lines except HUVEC, were cultured in their respective media supplemented with 10% FBS and 1% Penicillin/Streptomycin. HUVEC were grown in EGM-2 media (Lonza).
+ Open protocol
+ Expand
6

Evaluating CLDN6-Targeting Immunotherapy

Check if the same lab product or an alternative is used in the 5 most similar protocols
Target cells were the endogenously CLDN6-expressing (CLDN6+) human ovarian carcinoma cell lines PA-1 (teratocarcinoma), OV-90 (adenocarcinoma) (American Type Culture Collection) their firefly luciferase transduced variants (PA-1/luc, OV-90/luc) and the CLDN6-negative (CLDN6) human breast adenocarcinoma cell line MDA-MB-231/luc (Perkin Elmer). All cell lines have been authenticated by Eurofins in April 2015 (Human Cell Line Authentication Service by STR/DNA Profiling).
As effector cells human peripheral blood mononuclear cells (PBMC) isolated from buffy coats of healthy donors by Ficoll density-gradient centrifugation were used either as bulk or as T cells enriched by magnetic bead separation (Pan T Cell Kit II, human (Miltenyi)).
+ Open protocol
+ Expand
7

Breast Cancer and Melanoma Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human breast carcinoma cell line MDA-MB-231 stably expressing luciferase (MDA-MB-231.Luc) was purchased from PerkinElmer and cultured in EMEM containing 10% FBS. MDA-MB-231 expressing galectin-8-YFP (Gal8) was generated by Dr. Craig Duvall’s lab and cultured in DMEM containing 10% FBS, 1% Pen-Strep and Blasticidin (10 μg/mL). Mouse melanoma cell line B16F10 expressing luciferase (B16F10.Luc) was purchased from PerkinElmer and cultured in RPMI containing 10% FBS.
+ Open protocol
+ Expand
8

Cell Culture Protocols for Cancer Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK 293T human embryonic kidney cells, MDA-MB231 human breast tumor cells, MCF-7 human breast tumor cells, 4T1 mouse breast tumor cells, and Panc-1 human pancreatic tumor cells were purchased from American Type Culture Collection (ATCC, Rockville, MD). MDA-MB231-luc and 4T1-luc that express luciferase were obtained from Perkin Elmer (Waltham, MA). All cells were grown in Dulbecco's modified Eagle's medium (DMEM, HyClone, South Logan, UT) except MCF-7 cells, which were grown in Roswell park memorial institute medium (RPMI, HyClone). All media were supplemented with 10% fetal bovine serum (FBS, ThermoFisher Scientific, Waltham, MA). Cells were maintained at 37 °C in a humidified atmosphere containing 5% CO2.
+ Open protocol
+ Expand
9

Cancer Cell Signaling Pathway Study

Check if the same lab product or an alternative is used in the 5 most similar protocols
PF-03084014 and sunitinib were synthesized by Pfizer chemists. Unless otherwise noted, all chemicals were purchased from Sigma-Aldrich (St. Louis, MO). MDA-MB-231Luc and AngioSense 680 EX was purchased from PerkinElmer (Waltham, MA). The antibodies for IHC analyses were anti-BrdU (BD Pharmingen, San Diego, CA), anti-HIF1α (R&D Systems, Minneapolis, MN), anti-phospho-H2AX, anti-HES1, and anti-VEGFR2 (Cell Signaling Technology, Danvers, MA).
+ Open protocol
+ Expand
10

PKD3 Knockdown Reduces Metastasis in NOD SCID Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Animal experiments were performed under protocols A43213 and A17313 approved by the Mayo Clinic Institutional Animal Care and Use Committee (IACUC). Female non-obese diabetic severe combined immunodeficiency (NOD scid) mice were anesthetized, and 500,000 cells washed three times in PBS and mixed with 30 μl of complete Matrigel (BD Biosciences) were injected into the fourth mammary gland on the right side of each animal. As indicated, cell lines used were MDA-MB-231.Luc (MDA-MB-231-luc2 from Perkin Elmer; additionally expressing luciferase), MDA-MB-231.Luc stably expressing control shRNA (scr-shRNA) or two different shRNAs specifically-targeting PKD3 (PKD3-shRNA#1 and PKD3-shRNA#2). For studies with CRT0066101, mice were treated orally with 80 mg/kg CRT0066101 diluted in a 5 % dextrose saline solution (Sigma-Aldrich) or 5 % dextrose saline solution alone (control) every other day starting 14 days after cell injection. Body weight and tumor volume (caliper measurement) were determined once per week. The presence of metastases was detected using the IVIS Spectrum Imaging System (Perkin Elmer). At the end point, primary tumors and sites of metastasis were removed and analyzed as indicated.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!